Please login to the form below

Not currently logged in
Email:
Password:

Rexulti

This page shows the latest Rexulti news and features for those working in and with pharma, biotech and healthcare.

Lundbeck and Otsuka start phase III for Rexulti in bipolar

Lundbeck and Otsuka start phase III for Rexulti in bipolar

Lundbeck and Otsuka start phase III for Rexulti in bipolar. Drug is also in phase II trial to treat PTSD patients. ... To date Rexulti has only been launched in the US, Canada and Australia, although it was filed for approval in Europe in schizophrenia

Latest news

More from news
Approximately 3 fully matching, plus 5 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Real Science Communications

Real Science Communications is a scientific centre of excellence, infusing credibility and scientific rigour into the conversations around health and...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics